Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.

Meng Q, Garcia-Rodriguez C, Manzanarez G, Silberg MA, Conrad F, Bettencourt J, Pan X, Breece T, To R, Li M, Lee D, Thorner L, Tomic MT, Marks JD.

Anal Biochem. 2012 Nov 15;430(2):141-50. doi: 10.1016/j.ab.2012.08.005. Epub 2012 Aug 21.

2.

Deciphering antibody properties that lead to potent botulinum neurotoxin neutralization.

Marks JD.

Mov Disord. 2004 Mar;19 Suppl 8:S101-8. Review.

PMID:
15027061
3.

Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition.

Aoki KR, Smith LA, Atassi MZ.

Crit Rev Immunol. 2010;30(2):167-87. Review.

PMID:
20370628
4.

The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.

Rasetti-Escargueil C, Avril A, Miethe S, Mazuet C, Derman Y, Selby K, Thullier P, Pelat T, Urbain R, Fontayne A, Korkeala H, Sesardic D, Hust M, Popoff MR.

Toxins (Basel). 2017 Oct 2;9(10). pii: E309. doi: 10.3390/toxins9100309. Review.

5.

Oligoclonal antibodies to target the ErbB family.

D'Souza JW, Robinson MK.

Expert Opin Biol Ther. 2015 Jul;15(7):1015-21. doi: 10.1517/14712598.2015.1042362. Epub 2015 May 2. Review.

6.

Chemically programmed antibodies.

Rader C.

Trends Biotechnol. 2014 Apr;32(4):186-97. doi: 10.1016/j.tibtech.2014.02.003. Epub 2014 Mar 11. Review.

Supplemental Content

Support Center